Generating Alpha from Information Arbitrage in the Financial Markets with NLP Datasets: 水涨船高
Too Long; Didn't Read
On January 3rd 2019, Bristol-Myers Squibb (<a href="https://www.reuters.com/finance/stocks/companyProfile/BMY.O" target="_blank">BMY</a>) <a href="https://www.marketwatch.com/story/bristol-myers-squibb-agrees-to-acquire-celgene-for-about-74-billion-2019-01-03" target="_blank">acquired</a> Celgene (<a href="https://www.reuters.com/finance/stocks/companyProfile/CELG.O" target="_blank">CELG</a>) for $74 billion. CELG rose instantly overnight from 66.64 to 87.86 per share, giving it a 31.8% gain. Although most professionals missed out on these gains, there were other hidden opportunities to be had, if you knew where and how to find them.